Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.62 USD | -1.68% | +10.01% | +15.39% |
Mar. 18 | Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer | MT |
Mar. 18 | Fulcrum Therapeutics, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.39% | 482M | |
+21.76% | 47.9B | |
+46.62% | 41.42B | |
-2.18% | 40.7B | |
-6.20% | 28.92B | |
+10.19% | 25.55B | |
-20.87% | 19.27B | |
-0.32% | 12.15B | |
+31.04% | 12.14B | |
-0.47% | 11.99B |
- Stock Market
- Equities
- FULC Stock
- News Fulcrum Therapeutics, Inc.
- Goldman Sachs Adjusts Price Target on Fulcrum Therapeutics to $6 From $5, Maintains Neutral Rating